Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,202 INR | +3.21% | +2.11% | +10.92% |
05-08 | India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports | RE |
05-02 | Aurobindo Pharma Completes Sale of US Arm's Business Assets | MT |
Sales 2024 * | 287B 3.44B 4.69B | Sales 2025 * | 315B 3.78B 5.14B | Capitalization | 683B 8.2B 11.16B |
---|---|---|---|---|---|
Net income 2024 * | 31.34B 376M 513M | Net income 2025 * | 37.92B 455M 620M | EV / Sales 2024 * | 2.32 x |
Net cash position 2024 * | 18.34B 220M 300M | Net cash position 2025 * | 35.81B 430M 586M | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
21.8
x | P/E ratio 2025 * |
17.9
x | Employees | 23,451 |
Yield 2024 * |
0.35% | Yield 2025 * |
0.43% | Free-Float | 47.93% |
Latest transcript on Aurobindo Pharma
1 day | +3.21% | ||
1 week | +2.11% | ||
Current month | +4.24% | ||
1 month | +10.61% | ||
3 months | +15.52% | ||
6 months | +20.47% | ||
Current year | +10.92% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Director of Finance/CFO | - | 12-12-31 | |
B. Adi Reddy
CMP | Compliance Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Founder | 66 | 86-12-25 | |
Director/Board Member | 64 | 03-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 19 M€ | +9.88% | ||
0.12% | 11 M€ | +8.03% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1,165 | +0.44% | 1,301,547 |
24-05-16 | 1,160 | +0.13% | 699,002 |
24-05-15 | 1,158 | -0.87% | 1,001,585 |
24-05-14 | 1,169 | -0.76% | 1,704,299 |
24-05-13 | 1,178 | +4.44% | 3,504,915 |
Delayed Quote NSE India S.E., May 18, 2024 at 03:19 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.92% | 8.19B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- AUROPHARMA Stock